ZYUS — Zyus Life Sciences Share Price
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- CA$74.39m
- CA$76.14m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -5.73% | ||
| Return on Equity | -5.39% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 0 | 0 | 0 | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Phoenix Canada Oil Company Limited is a Canada-based company that is engaged in the investment management business sector. The Company maintains non-controlling equity investment positions in public companies. It also holds minority interest investments in several mature gas fields in Western Canada. The Company's objectives when managing capital are to maintain its ability to continue as a going concern in order to provide return for shareholders, and to ensure sufficient resources are available to meet daily operating requirements. The Company considers the items included in shareholders’ equity as capital. The Company manages its capital structure and adjusts it in order to have funds available to support its corporate activities.
Directors
- Charlotte Hepburn CHM
- Michael Kindy CFO
- Charles Burns IND
- Michael Detlefsen IND (57)
- William Mills IND
- Greg Nuttall IND
- Last Annual
- December 31st, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- November 25th, 1944
- Public Since
- July 17th, 2001
- No. of Employees
- 2
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 5,314,103
- Address
- 204 - 407 Downey Road, SASKATOON, S7N 4L8
- Web
- Phone
- +1 3062422357
- Auditors
- MNP LLP
Upcoming Events for ZYUS
Similar to ZYUS
Arch Biopartners
TSX Venture Exchange
biOasis Technologies
TSX Venture Exchange
Ceapro
TSX Venture Exchange
Covalon Technologies
TSX Venture Exchange
Hemostemix
TSX Venture Exchange
FAQ
What is the Zyus Life Sciences share price?
As of Today at 19:24 UTC, shares in Zyus Life Sciences are trading at CA$0.85. This share price information is delayed by 15 minutes.
How has the Zyus Life Sciences share price performed this year?
Shares in Zyus Life Sciences last closed at CA$0.85 and the price had moved by -33.59% over the past 365 days. In terms of relative price strength the Zyus Life Sciences share price has underperformed the Toronto Stock Exchange 300 Composite Index by -37.07% over the past year.
What are the analyst and broker recommendations for Zyus Life Sciences?
There is no consensus recommendation for this security.
What is the Zyus Life Sciences dividend yield?
Zyus Life Sciences does not currently pay a dividend.
Does Zyus Life Sciences pay a dividend?
Zyus Life Sciences does not currently pay a dividend.
When does Zyus Life Sciences next pay dividends?
Zyus Life Sciences does not currently pay a dividend.
How do I buy Zyus Life Sciences shares?
To buy shares in Zyus Life Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zyus Life Sciences?
As of the previous close price of CA$0.85, shares in Zyus Life Sciences had a market capitalisation of .
Where are Zyus Life Sciences shares listed?
Here are the trading details for Zyus Life Sciences:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: PCO
What kind of share is Zyus Life Sciences?
Based on an overall assessment of its quality, value and momentum Zyus Life Sciences is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zyus Life Sciences share price forecast for 2023?
We could not find analyst target price data for this security.
What is the trend in the Zyus Life Sciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zyus Life Sciences. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -32.48%.
As of the last closing price of CA$0.85, shares in Zyus Life Sciences were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zyus Life Sciences PE Ratio?
The Zyus Life Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zyus Life Sciences?
Zyus Life Sciences' management team is headed by:
- Charlotte Hepburn - CHM
- Michael Kindy - CFO
- Charles Burns - IND
- Michael Detlefsen - IND
- William Mills - IND
- Greg Nuttall - IND